Zentalis Pharmaceuticals 将来の成長
Future 基準チェック /26
Zentalis Pharmaceuticalsの収益は年間0.1%で減少すると予測されていますが、年間収益は年間37%で増加すると予測されています。EPS は年間 増加すると予測されています。自己資本利益率は 3 年後に-107.1% 8.1%なると予測されています。
主要情報
-0.1%
収益成長率
8.1%
EPS成長率
| Biotechs 収益成長 | 28.3% |
| 収益成長率 | 37.0% |
| 将来の株主資本利益率 | -107.1% |
| アナリストカバレッジ | Good |
| 最終更新日 | 15 Nov 2024 |
今後の成長に関する最新情報
Results: Zentalis Pharmaceuticals, Inc. Confounded Analyst Expectations With A Surprise Profit
May 09
Recent updates
We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Needs To Drive Business Growth Carefully
Oct 03Broker Revenue Forecasts For Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Are Surging Higher
Jun 19We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Jun 13Results: Zentalis Pharmaceuticals, Inc. Confounded Analyst Expectations With A Surprise Profit
May 09Zentalis Pharmaceuticals: Data In 1st Half Of 2024 Could Get The Ball Rolling
Apr 12We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth
Feb 29Zentalis: Leading WEE1 Developer After AstraZeneca's Exit
Feb 05Is Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Trading At A 45% Discount?
Jan 09We're Not Very Worried About Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Rate
Oct 13We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth
Jun 30We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Mar 17We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Dec 01Zentalis Pharmaceuticals promotes co-founder Kevin Bunker to chief scientific officer
Sep 27Zentalis Pharmaceuticals has a new chief medical officer
Sep 19Zentalis Pharmaceuticals (NASDAQ:ZNTL) Is In A Good Position To Deliver On Growth Plans
Aug 17Here's Why We're Not Too Worried About Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Situation
May 02We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Jan 12We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Oct 14Companies Like Zentalis Pharmaceuticals (NASDAQ:ZNTL) Are In A Position To Invest In Growth
Jul 02Have Insiders Sold Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Recently?
Mar 08Companies Like Zentalis Pharmaceuticals (NASDAQ:ZNTL) Are In A Position To Invest In Growth
Jan 20業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 23 | -246 | -220 | -268 | 8 |
| 12/31/2025 | N/A | -233 | -194 | -232 | 9 |
| 12/31/2024 | 41 | -173 | -169 | -174 | 11 |
| 9/30/2024 | 41 | -179 | -172 | -172 | N/A |
| 6/30/2024 | 41 | -195 | -167 | -166 | N/A |
| 3/31/2024 | 41 | -219 | -211 | -211 | N/A |
| 12/31/2023 | N/A | -292 | -208 | -208 | N/A |
| 9/30/2023 | N/A | -286 | -205 | -205 | N/A |
| 6/30/2023 | N/A | -285 | -201 | -199 | N/A |
| 3/31/2023 | N/A | -241 | -165 | -163 | N/A |
| 12/31/2022 | N/A | -237 | -166 | -164 | N/A |
| 9/30/2022 | N/A | -232 | -168 | -163 | N/A |
| 6/30/2022 | N/A | -182 | -169 | -164 | N/A |
| 3/31/2022 | N/A | -168 | -173 | -167 | N/A |
| 12/31/2021 | N/A | -159 | -160 | -154 | N/A |
| 9/30/2021 | N/A | -149 | -149 | -144 | N/A |
| 6/30/2021 | N/A | -179 | -133 | -132 | N/A |
| 3/31/2021 | N/A | -152 | -109 | -107 | N/A |
| 12/31/2020 | N/A | -118 | -88 | -87 | N/A |
| 9/30/2020 | N/A | -92 | -73 | -73 | N/A |
| 6/30/2020 | N/A | -70 | -62 | -62 | N/A |
| 3/31/2020 | N/A | -53 | -47 | -47 | N/A |
| 12/31/2019 | N/A | -46 | -39 | -39 | N/A |
| 12/31/2018 | 0 | -23 | -24 | -24 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: ZNTL今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: ZNTL今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: ZNTL今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: ZNTLの収益 ( 37% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。
高い収益成長: ZNTLの収益 ( 37% ) 20%よりも速いペースで成長すると予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: ZNTL 3 年以内に赤字になると予測されています。